Related Experiment Video
Updated: Aug 22, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Voice Tremor and Botulinum Neurotoxin Therapy: A Contemporary Review
David P Newland1, Daniel Novakovic2,3, Amanda L Richards1
1Department of Otolaryngology, The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.
Understanding voice tremor, a common symptom of neurological disorders, is crucial for effective treatment. Botulinum neurotoxin shows promise, but careful patient selection is key for optimal outcomes.
Area of Science:
- Neurology
- Otolaryngology
- Speech Pathology
Background:
- Voice tremor is a frequent and disabling symptom in various tremor disorders.
- Understanding the underlying pathophysiology and accurate diagnosis are essential for effective treatment strategies.
- Essential tremor can also manifest with voice tremor, complicating diagnosis and management.
Purpose of the Study:
- To review the current understanding of voice tremor, including its pathophysiology, diagnosis, and treatment options.
- To specifically evaluate the role of botulinum neurotoxin in managing voice tremor.
- To emphasize the importance of patient selection for optimizing therapeutic outcomes.
Main Methods:
- A comprehensive literature review was conducted.
- The review focused on studies detailing voice tremor characteristics, diagnostic methods, and treatment efficacy.
- Particular attention was given to botulinum neurotoxin therapy and patient selection criteria.
Main Results:
- Accurate characterization of voice tremor qualities is vital for successful treatment.
- Botulinum neurotoxin therapy can be effective when judiciously applied to carefully selected patients.
- Current treatment strategies require further refinement based on detailed patient response data.
Conclusions:
- Effective management of voice tremor necessitates a deep understanding of its mechanisms and precise diagnosis.
- Optimizing botulinum neurotoxin therapy relies heavily on appropriate patient selection based on tremor characteristics.
- Further research is needed to fully elucidate treatment responses and develop novel therapeutic interventions for voice tremor.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Direct-Acting Cholinergic Agonists: Therapeutic Uses

